Detalhe da pesquisa
1.
Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.
Int J Cancer
; 152(3): 511-523, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069222
2.
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma.
Commun Med (Lond)
; 4(1): 89, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760583
3.
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma.
Cell Rep
; 42(6): 112581, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269289
4.
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth.
Front Cell Dev Biol
; 9: 743907, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34646829